31.05.2015 Views

NcXHF

NcXHF

NcXHF

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PAGE ET AL<br />

$350 per month per patient). The regimens were selected by<br />

an expert physician panel based on outcomes from the medical<br />

literature. Anthem expects the lower total cost of the selected<br />

regimens to fund the program payments. There is no<br />

penalty for using other regimens.<br />

Risk sharing or gain sharing is the next progression of payment<br />

risk. Physicians in these programs have their managed<br />

patient’s outcomes measured and compared with another<br />

similar population. Any savings in the managed group is<br />

shared between the payer and the clinicians. Gain sharing is<br />

participation only in savings, whereas, risk sharing often implies<br />

that the physician would share in losses as well. The key<br />

to an accurate program assessment is the quality of the comparison<br />

group. Many risk-sharing contracts utilize a year<br />

over the previous year comparison within the same practice.<br />

This method often cannot adjust for the change in patient<br />

diagnosis mix resulting in an inaccurate assessment of savings.<br />

The ideal comparison group is treated during similar<br />

timeframes and can be risk adjusted to match those patients<br />

in the managed practice. The approach is no different than a<br />

well-conducted clinical trial.<br />

The next progression of risk is the bundled payment, which<br />

is the ambulatory equivalent of the Diagnosis Related Group<br />

(DRG) used for hospital reimbursement. A fıxed payment is<br />

made to the provider for the services required to care for a<br />

specifıc diagnosis. These payments often include multiple<br />

disciplines and facilities. The recent MD Anderson Cancer<br />

Center contract with UnitedHealthcare illustrates the components<br />

of a bundled payment. Patients with head and neck<br />

cancer are evaluated at the cancer center and assigned to one<br />

of four risk categories. All of the services required for the<br />

complete treatment of this patient are included under a single<br />

payment from the payer. The bundle covers a 1-year time<br />

period including complications. Bundles provide the incentive<br />

to remove all of the unnecessary or nonvalue services to<br />

maximize profıt. The MD Anderson Cancer Center used a<br />

systematic approach to map the processes for head and neck<br />

cancer treatment and activity-based accounting to identify<br />

and remove unessential care. Similar to the DRG, the elimination<br />

of complications is the other substantial way to improve<br />

profıts under this payment system. Quality pays in<br />

bundled payments.<br />

Capitation is the highest form of risk. The capitated provider<br />

assumes complete fınancial responsibility for all cancer<br />

care in a population of patients within a fıxed budget. The<br />

population must be well defıned with risk profıling, and actuarial<br />

expertise is essential to manage this type of payment.<br />

Very few organizations are capable of undertaking this type<br />

of contracting and the authors discourage providers from attempting<br />

this approach until they have mastered other<br />

lower-risk programs.<br />

IMPORTANCE OF ESTABLISHING PERFORMANCE<br />

MEASURES<br />

Medical practices who assume risk need infrastructure to understand<br />

the processes they use to evaluate and treat their<br />

patients. Mapping those processes will be both enlightening<br />

and startling because inconsistency is usually the norm.<br />

Adopting and driving standard approaches to common<br />

problems eliminates waste and increases productivity—<br />

changes that make risk contracting a profıtable approach. At<br />

the same time, the new understanding of patient care performance<br />

drives higher quality with fewer errors, better communication,<br />

and rapid identifıcation of patient problems.<br />

Those new changes are managed with internal performance<br />

measures. No practice should assume things are<br />

changing because they signed a risk contract; the change<br />

must be measured and managed. These internal, quality improvement<br />

measures can be less rigorous than external measures<br />

and they can be adjusted frequently. The purpose of<br />

these measures is not to obtain complete accuracy, but rather<br />

to identify trends quickly and make adjustments. Adopting<br />

this type of measure is diffıcult for physicians who are used to<br />

exact measures of performance.<br />

External measures are more rigorous and are often tied to<br />

compensation. These measures should be limited to the vital<br />

few because the data collection and analysis are time consuming.<br />

Regulators often require multiple measures as an assurance<br />

of quality in risk programs, but if too many measures<br />

are required it can discourage participation by physicians.<br />

Further, risk payment should not be hindered by measures<br />

that are not required of FFS providers. The best external measures<br />

are quite simple: survival, either disease-free or overall,<br />

and total cost of care. Adding process measures that contribute<br />

to these two ultimate measures distract physician resources<br />

during the risk contract.<br />

These principles have moved beyond the theoretical. A recent<br />

pilot for a gain-sharing episode payment demonstrated<br />

a 34% savings in the trial cohort compared to matched controls<br />

in FFS payment models. 5 The MD Anderson Cancer<br />

Center has initiated a full bundled payment for patients with<br />

head and neck cancer. Models like these have the potential to<br />

drive higher quality care while simultaneously saving money<br />

by eliminating unnecessary care.<br />

COME HOME OUTCOMES AND SUSTAINABILITY<br />

OMHs have been shown by the COME HOME Program to<br />

meet the triple aim: Patient care is improved, and patient outcomes<br />

are better (lower ED visit rate, lower inpatient admission<br />

rate, fewer inpatient days) with consistently high patient<br />

satisfaction, all at an equal or often lower cost than local comparator<br />

groups.<br />

Participating oncology practices provide all outpatient<br />

cancer care, including triage pathways that ensure patients<br />

receive the right care in the right place at the right time for<br />

symptoms related to cancer and cancer treatment (Fig. 2),<br />

and clinical pathways that address appropriate imaging,<br />

pathologic testing, and molecular diagnostics, and delineate<br />

chemotherapy, radiation oncology, supportive care, and surgery<br />

(when applicable). The best practices offered by OMHs<br />

include patient education and medication management<br />

counseling, team-based care, 24/7 practice access (telephone<br />

e84<br />

2015 ASCO EDUCATIONAL BOOK | asco.org/edbook

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!